• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Superconnector
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEW
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form S-8 filed by Senseonics Holdings Inc.

    8/6/25 4:40:36 PM ET
    $SENS
    Industrial Machinery/Components
    Industrials
    Get the next $SENS alert in real time by email
    S-8 1 tm2522556d1_s8.htm FORM S-8

     

    As filed with the Securities and Exchange Commission on August 6, 2025

     

    Registration No. 333-

     

     

     

    UNITED STATES

    SECURITIES AND EXCHANGE COMMISSION

    Washington, D.C. 20549

     

     

     

    FORM S-8

    REGISTRATION STATEMENT

    UNDER

    THE SECURITIES ACT OF 1933

     

     

     

    Senseonics Holdings, Inc.

    (Exact name of Registrant as specified in its charter)

     

    Delaware   47-1210911
    (State or other jurisdiction of Incorporation or
    organization)
      (I.R.S. Employer Identification No.)

     

    20451 Seneca Meadows Parkway

    Germantown, MD 20876-7005

    (Address of principal executive offices) (Zip code)

     

    Amended and Restated 2015 Equity Incentive Plan

    2016 Employee Stock Purchase Plan

    (Full title of the plan)

     

    Timothy T. Goodnow

    President and Chief Executive Officer

    Senseonics Holdings, Inc.

    20451 Seneca Meadows Parkway

    Germantown, MD 20876-7005

    (301) 515-7260

    (Name and address of agent for service) (Telephone number, including area code, of agent for service)

    Copies to:

    Darren K. DeStefano
    Reid Hooper
     
    Cooley LLP
    11951 Freedom Drive
    Reston, VA 20190
    (703) 456-8000
    Rick Sullivan
     
    Chief Financial Officer
    Senseonics Holdings, Inc.
    20451 Seneca Meadows Parkway
    Germantown, MD 20876-7005
    (301) 515-7260

     

    Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

     

    Large accelerated filer ¨   Accelerated filer ¨ 
    Non-accelerated filer x   Smaller reporting company x  
          Emerging growth company ¨

     

    If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 7(a)(2)(B) of the Securities Act. ¨

     

     

     

     

     

     

    EXPLANATORY NOTE

     

    This Registration Statement on Form S-8 (the “Registration Statement”) is being filed for the purpose of registering an additional 86,311,952 shares of common stock of Senseonics Holdings, Inc. (the “Registrant”) issuable pursuant to the Senseonics Holdings, Inc. Amended and Restated 2015 Equity Incentive Plan (the “2015 EIP”) and 2016 Employee Stock Purchase Plan (the “2016 ESPP”). These additional shares of Common Stock are securities of the same class as other securities for which an original registration statement on Form S-8 (File No. 333-210586) was filed with the Securities and Exchange Commission (the “Commission”) on April 4, 2016. Accordingly, the contents of the Registrant’s registration statements on Form S-8 filed with the Commission on April 4, 2016 (File No. 333-210586), May 10, 2018 (File No. 333-224827), May 9, 2019 (File No. 333-231334) and May 26, 2022 (File No. 333-265241) are incorporated by reference into this Registration Statement pursuant to General Instruction E of Form S-8. These additional shares of common stock have become reserved for issuance as a result of the operation of the “evergreen” provision in the 2015 EIP and 2016 ESPP, which provides that the total number of shares subject to such plan may be increased each year pursuant to a specified formula.

     

    PART II

     

    ITEM 3. INCORPORATION OF DOCUMENTS BY REFERENCE

     

    The Registrant is subject to the informational and reporting requirements of Section 12(b) of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), and in accordance therewith files reports and other information with the Securities and Exchange Commission (the “Commission”). The following documents filed by the Registrant with the Commission pursuant to the Exchange Act are incorporated by reference in this Registration Statement:

     

    (a)The Registrant’s Annual Report on Form 10-K (File No. 001-37717) for the fiscal year ended December 31, 2024, filed with the Commission on March 3, 2025;

     

    (b)The Registrant’s Definitive Proxy Statement on Schedule 14A for the 2025 Annual Meeting of Stockholders (File No. 001-37717) filed with the Commission on April 10, 2025;

     

    (c)The Registrant’s Current Report on Form 10-Q (File No. 001-37717) for the fiscal quarters ended March 31, 2025 and June 30, 2025, filed with the Commission on May 8, 2025 and August 6, 2025;

     

    (d)The Registrant’s Current Reports on Form 8-K (File No. 001-37717) filed with the Commission on January 13, 2025, January 17, 2025, May 15, 2025, May 16, 2025 (as amended on May 19, 2025) and May 21, 2025; and

     

    (e)The Registrant’s description of its common stock contained in its registration statement on Form 8-A, filed with the SEC on March 11, 2016, as updated by Exhibit 4.3 to its Annual Report on Form 10-K filed with the Commission on March 3, 2025, including any amendment or report filed for the purpose of updating such description.

     

    All documents, reports and definitive proxy or information statements filed pursuant to Section 13(a), 13(c), 14 or 15(d) of the Exchange Act after the date of this Registration Statement and prior to the filing of a post-effective amendment which indicates that all securities offered hereby have been sold or which deregisters all securities then remaining unsold, shall be deemed to be incorporated by reference into this Registration Statement and to be a part hereof from the date of filing of such documents; provided, however, that documents, reports and definitive proxy or information statements, or portions thereof, which are furnished and not filed in accordance with the rules of the Commission shall not be deemed incorporated by reference into this Registration Statement. Any statement contained in a document incorporated or deemed to be incorporated herein by reference shall be deemed to be modified or superseded for purposes of this Registration Statement to the extent that a statement herein or in any other subsequently filed document which also is or is deemed to be incorporated by reference herein modifies or supersedes that statement. Any such statement so modified or superseded shall not constitute a part of this Registration Statement, except as so modified or superseded.

     

     

     

     

    ITEM 8. EXHIBITS

     

    Exhibit
    Number
      Description
    4.1(1)   Amended and Restated Certificate of Incorporation, as currently in effect.
    4.2(2)   Certificate of Amendment to Amended and Restated Certificate of Incorporation.
    4.3(3)   Certificate of Amendment to Amended and Restated Certificate of Incorporation.
    4.4(4)   Certificate of Amendment to Amended and Restated Certificate of Incorporation.
    4.5(5)   Amended and Restated Bylaws, as currently in effect.
    4.6(6)   Amendment to Bylaws.
    4.7(7)   Certificate of Designation of Preferences, Rights and Limitations of Series A Convertible Preferred Stock.
    4.8(8)   Certificate of Designation of Preferences, Rights and Limitations of Series B Convertible Preferred Stock.
    4.9(9)   Specimen stock certificate evidencing shares of Common Stock.
    4.10(10)   Amended and Restated 2015 Equity Incentive Plan.
    4.11(11)   Form of Stock Option Grant Notice and Stock Option Agreement under Amended and Restated 2015 Equity Incentive Plan.
    4.12(12)   Form of Restricted Stock Unit Grant Notice and Restricted Stock Unit Award Agreement under Amended and Restated 2015 Equity Incentive Plan.
    4.13(13)   2016 Employee Stock Purchase Plan.
    5.1   Opinion of Cooley LLP.
    23.1   Consent of KPMG LLP, independent registered public accounting firm.
    23.2   Consent of Cooley LLP (included in Exhibit 5.1).
    24.1   Power of Attorney (included on the signature page of this Form S-8).
    107   Filing Fee Table.

     

    (1) Previously filed as Exhibit 3.1 to the Registrant’s Current Report on Form 8-K (File No. 001-37717), filed with the Commission on March 23, 2016, and incorporated by reference herein.

    (2) Previously filed as Exhibit 3.3 to the Registrant’s Quarterly Report on Form 10-Q for the Quarter ended June 30, 2018 (File No. 001-37717), filed with the Commission on August 8, 2018, and incorporated by reference herein.

    (3) Previously filed as Exhibit 3.1 to the Registrant’s Current Report on Form 8-K (File No. 001-37717), filed with the Commission on October 26, 2020. , and incorporated by reference herein.

    (4) Previously filed as Exhibit 3.1 to the Registrant’s Current Report on Form 8-K (File No. 001-37717), filed with the Commission on May 22, 2024, and incorporated by reference herein.

    (5) Previously filed as Exhibit 3.2 to the Registrant’s Current Report on Form 8-K (File No. 001-37717), filed with the Commission on March 23, 2016, and incorporated by reference herein.

    (6) Previously filed as Exhibit 3.7 to the Registrant’s Annual Report on Form 10-K (File No. 001-37717), filed with the Commission on March 5, 2021, and incorporated by reference herein.

    (7) Previously filed as Exhibit 3.1 to the Registrant’s Current Report on Form 8-K (File No. 001-37717), filed with the Commission on August 18, 2020, and incorporated by reference herein.

    (8) Previously filed as Exhibit 3.5 to the Registrant’s Quarterly Report on Form 10-Q (File No. 001-37717), filed with the Commission on November 8, 2022, and incorporated by reference herein.

    (9) Previously filed as Exhibit 4.2 to Amendment No. 2 to the Registrant’s Registration Statement on Form S-1 (File No. 333-208984), filed with the Commission on March 8, 2016, and incorporated by reference herein.

    (10) Previously filed as Exhibit 4.7 to the Registrant’s Registration Statement on Form S-8 (File No. 333-210586), filed with the Commission on April 4, 2016, and incorporated by reference herein.

    (11) Previously filed as Exhibit 10.7 to the Registrant’s Current Report on Form 8-K (File No. 333-198168), filed with the Commission on December 10, 2015, and incorporated by reference herein.

    (12) Previously filed as Exhibit 10.8 to the Registrant’s Current Report on Form 8-K (File No. 333-198168), filed with the Commission on December 10, 2015, and incorporated by reference herein.

    (13) Previously filed as Exhibit 4.10 to the Registrant’s Registration Statement on Form S-8 (File No. 333-210586), filed with the Commission on April 4, 2016, and incorporated by reference herein.

     

     

     

     

    SIGNATURES

     

    Pursuant to the requirements of the Securities Act of 1933, as amended, the Registrant certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form S-8 and has duly caused this Registration Statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of Germantown, State of Maryland, on this sixth day of August 2025.

     

    SENSEONICS HOLDINGS, INC.    
       
    By: /s/ Timothy T. Goodnow  
      Timothy T. Goodnow  
      President and Chief Executive Officer  

     

    POWER OF ATTORNEY

     

    Know All Persons By These Presents, that each person whose signature appears below constitutes and appoints Timothy T. Goodnow and Rick Sullivan, and each or any one of them, his or her true and lawful attorney-in-fact and agent, with full power of substitution and resubstitution, for him or her and in his or her name, place and stead, in any and all capacities, to sign any and all amendments (including post-effective amendments) to this Registration Statement, and to file the same, with all exhibits thereto, and other documents in connection therewith, with the Securities and Exchange Commission, granting unto said attorneys-in-fact and agents, and each of them, full power and authority to do and perform each and every act and thing requisite and necessary to be done in connection therewith, as fully to all intents and purposes as he might or could do in person, hereby ratifying and confirming all that said attorneys-in-fact and agents, or any of them, or their or his or her substitutes or substitute, may lawfully do or cause to be done by virtue hereof.

     

    Pursuant to the requirements of the Securities Act of 1933, as amended, this Registration Statement has been signed by the following persons in the capacities and on the dates indicated.

     

    Signature   Title   Date
             
    /s/ Timothy T. Goodnow. Ph.D.   President, Chief Executive Officer and Director (Principal Executive Officer)   August 6, 2025
    Timothy T. Goodnow      
             
    /s/ Rick Sullivan   Chief Financial Officer (Principal Financial Officer and Principal Accounting Officer)   August 6, 2025
    Rick Sullivan      
             
    /s/ Stephen P. DeFalco   Chairman of the Board of Directors   August 6, 2025
    Stephen P. DeFalco        
             
    /s/ Steven Edelman, M.D.   Director   August 6, 2025
    Steven Edelman        
             
    /s/ Brian Hansen   Director   August 6, 2025
    Brian Hansen        
             
    /s/ Edward J. Fiorentino   Director   August 6, 2025
    Edward J. Fiorentino        
             
    /s/ Francine Kaufman, M.D.   Director and Chief Medical Officer   August 6, 2025
    Francine Kaufman        
             
    /s/ Sharon Larkin   Director   August 6, 2025
    Sharon Larkin        
             
    /s/ Douglas S. Prince   Director   August 6, 2025
    Douglas S. Prince        
             
    /s/ Koichiro Sato   Director   August 6, 2025
    Koichiro Sato        
             
    /s/ Douglas A. Roeder   Director   August 6, 2025
    Douglas A. Roeder        

     

     

     

    Get the next $SENS alert in real time by email

    Crush Q3 2025 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $SENS

    DatePrice TargetRatingAnalyst
    8/27/2025$1.50Overweight
    Barclays
    7/15/2025$1.25Buy
    TD Cowen
    6/2/2025$1.10Buy
    H.C. Wainwright
    4/10/2025$2.00Outperform
    Mizuho
    7/19/2023$0.50Underperform
    Jefferies
    8/19/2021$6.00Buy
    HC Wainwright & Co.
    More analyst ratings

    $SENS
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Prince Douglas S was granted 17,069 shares, increasing direct ownership by 2% to 1,087,607 units (SEC Form 4)

    4 - Senseonics Holdings, Inc. (0001616543) (Issuer)

    7/3/25 4:15:40 PM ET
    $SENS
    Industrial Machinery/Components
    Industrials

    Director Steven Edelman was granted 27,048 shares, increasing direct ownership by 2% to 1,263,001 units (SEC Form 4)

    4 - Senseonics Holdings, Inc. (0001616543) (Issuer)

    7/3/25 4:15:32 PM ET
    $SENS
    Industrial Machinery/Components
    Industrials

    Director Roeder Douglas A was granted 30,987 shares, increasing direct ownership by 2% to 1,658,826 units (SEC Form 4)

    4 - Senseonics Holdings, Inc. (0001616543) (Issuer)

    7/3/25 4:15:35 PM ET
    $SENS
    Industrial Machinery/Components
    Industrials

    $SENS
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Barclays initiated coverage on Senseonics with a new price target

    Barclays initiated coverage of Senseonics with a rating of Overweight and set a new price target of $1.50

    8/27/25 8:26:33 AM ET
    $SENS
    Industrial Machinery/Components
    Industrials

    TD Cowen initiated coverage on Senseonics with a new price target

    TD Cowen initiated coverage of Senseonics with a rating of Buy and set a new price target of $1.25

    7/15/25 8:44:36 AM ET
    $SENS
    Industrial Machinery/Components
    Industrials

    H.C. Wainwright resumed coverage on Senseonics with a new price target

    H.C. Wainwright resumed coverage of Senseonics with a rating of Buy and set a new price target of $1.10

    6/2/25 8:54:33 AM ET
    $SENS
    Industrial Machinery/Components
    Industrials

    $SENS
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Amendment: Director Roeder Douglas A bought $37,500 worth of shares (75,000 units at $0.50), increasing direct ownership by 5% to 1,463,087 units (SEC Form 4)

    4/A - Senseonics Holdings, Inc. (0001616543) (Issuer)

    12/20/24 5:37:53 PM ET
    $SENS
    Industrial Machinery/Components
    Industrials

    Director Roeder Douglas A bought $135,500 worth of shares (325,000 units at $0.42), increasing direct ownership by 30% to 1,413,087 units (SEC Form 4)

    4 - Senseonics Holdings, Inc. (0001616543) (Issuer)

    12/16/24 4:21:25 PM ET
    $SENS
    Industrial Machinery/Components
    Industrials

    Chief Financial Officer Sullivan Frederick T. bought $47,475 worth of shares (124,933 units at $0.38), increasing direct ownership by 5% to 2,478,844 units (SEC Form 4)

    4 - Senseonics Holdings, Inc. (0001616543) (Issuer)

    12/12/24 7:04:14 PM ET
    $SENS
    Industrial Machinery/Components
    Industrials

    $SENS
    SEC Filings

    View All

    SEC Form EFFECT filed by Senseonics Holdings Inc.

    EFFECT - Senseonics Holdings, Inc. (0001616543) (Filer)

    8/19/25 12:15:16 AM ET
    $SENS
    Industrial Machinery/Components
    Industrials

    SEC Form 424B3 filed by Senseonics Holdings Inc.

    424B3 - Senseonics Holdings, Inc. (0001616543) (Filer)

    8/18/25 4:36:27 PM ET
    $SENS
    Industrial Machinery/Components
    Industrials

    SEC Form DEF 14A filed by Senseonics Holdings Inc.

    DEF 14A - Senseonics Holdings, Inc. (0001616543) (Filer)

    8/18/25 7:30:29 AM ET
    $SENS
    Industrial Machinery/Components
    Industrials

    $SENS
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G/A filed by Senseonics Holdings Inc. (Amendment)

    SC 13G/A - Senseonics Holdings, Inc. (0001616543) (Subject)

    2/13/24 5:13:59 PM ET
    $SENS
    Industrial Machinery/Components
    Industrials

    SEC Form SC 13G/A filed by Senseonics Holdings Inc. (Amendment)

    SC 13G/A - Senseonics Holdings, Inc. (0001616543) (Subject)

    7/7/23 4:35:55 PM ET
    $SENS
    Industrial Machinery/Components
    Industrials

    SEC Form SC 13G filed by Senseonics Holdings Inc.

    SC 13G - Senseonics Holdings, Inc. (0001616543) (Subject)

    4/10/23 5:10:45 PM ET
    $SENS
    Industrial Machinery/Components
    Industrials

    $SENS
    Financials

    Live finance-specific insights

    View All

    Senseonics Signs Memorandum of Understanding with Ascensia Diabetes Care to Take Over Commercialization and Distribution of Eversense 365

    CGM commercial operations to transition from Ascensia Diabetes Care to Senseonics Brian Hansen to be appointed Chief Commercial Officer Non-dilutive debt facility expanded up to $100 million with Hercules Capital to fund commercial organization Conference Call scheduled for September 4, 2025 at 8:00 A.M. Eastern Time GERMANTOWN, Md., Sept. 03, 2025 (GLOBE NEWSWIRE) -- Senseonics Holdings, Inc. (NYSE:SENS) a medical technology company focused on the development and manufacturing of long-term, implantable continuous glucose monitoring (CGM) systems for people with diabetes, today announced a mutually executed Memorandum of Understanding to transition all commercialization and distributio

    9/3/25 5:17:09 PM ET
    $HTGC
    $SENS
    Investment Managers
    Finance
    Industrial Machinery/Components
    Industrials

    Senseonics Holdings, Inc. Schedules Second Quarter 2025 Earnings Release and Conference Call for August 6, 2025 at 4:30 P.M. Eastern Time

    GERMANTOWN, Md., July 16, 2025 (GLOBE NEWSWIRE) -- Senseonics Holdings, Inc. (NYSE:SENS), a medical technology company focused on the development and manufacturing of long-term, implantable continuous glucose monitoring (CGM) systems for people with diabetes, today announced that it plans to release its second quarter 2025 financial results after market close on Wednesday, August 6, 2025. Management will hold a conference call to review the Company's second quarter 2025 performance starting at 4:30 p.m. (Eastern Time) on the same day. The conference call will be concurrently webcast. The link to the webcast will be available on Senseonics Holdings, Inc. website at www.senseonics.com by na

    7/16/25 4:05:00 PM ET
    $SENS
    Industrial Machinery/Components
    Industrials

    Senseonics Holdings, Inc. Reports First Quarter Financial Results

    Q1 Revenue of $6.3 million, growth year over year of 24% Partnership with Sequel integrates twiist™ automated insulin delivery (AID) system with Eversense® 365 one-year continuous glucose monitor (CGM); twiist with Eversense 365 launch expected in Q3 GERMANTOWN, Md., May 08, 2025 (GLOBE NEWSWIRE) -- Senseonics Holdings, Inc. (NYSE:SENS), a medical technology company focused on the development and manufacturing of long-term, implantable continuous glucose monitoring (CGM) systems for people with diabetes, today reported financial results for the first quarter ended March 31, 2025. Recent Highlights & Accomplishments: Generated revenue of $6.3 million in the first quarter of 2025CMS upda

    5/8/25 4:05:00 PM ET
    $SENS
    Industrial Machinery/Components
    Industrials

    $SENS
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Ascensia Diabetes Care Signs MOU to Transfer Eversense® CGM Distribution to Strategic Partner Senseonics

    - Agreement with Senseonics to transfer commercial activities would integrate Eversense manufacturing and distribution to accelerate growth PHC Holdings Corporation (President, Representative Director and CEO: Kyoko Deguchi, TSE: 6523) and its subsidiary Ascensia Diabetes Care, a global diabetes care company, today announced that Ascensia has signed a memorandum of understanding to transfer the commercial operations for Eversense® Continuous Glucose Monitoring (CGM) systems to Eversense maker Senseonics Holdings, Inc. (NYSE:SENS). The companies are targeting to unite Eversense R&D, manufacturing, and commercial activities within Senseonics beginning January 1, 2026, subject to a definitiv

    9/3/25 7:22:00 PM ET
    $SENS
    Industrial Machinery/Components
    Industrials

    Senseonics Signs Memorandum of Understanding with Ascensia Diabetes Care to Take Over Commercialization and Distribution of Eversense 365

    CGM commercial operations to transition from Ascensia Diabetes Care to Senseonics Brian Hansen to be appointed Chief Commercial Officer Non-dilutive debt facility expanded up to $100 million with Hercules Capital to fund commercial organization Conference Call scheduled for September 4, 2025 at 8:00 A.M. Eastern Time GERMANTOWN, Md., Sept. 03, 2025 (GLOBE NEWSWIRE) -- Senseonics Holdings, Inc. (NYSE:SENS) a medical technology company focused on the development and manufacturing of long-term, implantable continuous glucose monitoring (CGM) systems for people with diabetes, today announced a mutually executed Memorandum of Understanding to transition all commercialization and distributio

    9/3/25 5:17:09 PM ET
    $HTGC
    $SENS
    Investment Managers
    Finance
    Industrial Machinery/Components
    Industrials

    Senseonics Holdings, Inc. Reports Second Quarter Financial Results

    Generated Q2 revenue of $6.6 million, representing year-over-year growth of 37% Achieved a 79% increase in U.S. new patient starts over prior year GERMANTOWN, Md., Aug. 06, 2025 (GLOBE NEWSWIRE) -- Senseonics Holdings, Inc. (NYSE:SENS), a medical technology company focused on the development and manufacturing of long-term, implantable continuous glucose monitoring (CGM) systems for people with diabetes, today reported financial results for the second quarter ended June 30, 2025. Recent Highlights & Accomplishments: Generated revenue of $6.6 million in the second quarter of 2025, an increase of 37% versus the second quarter of 2024, driven by 79% new patient growth in the U.S. over prio

    8/6/25 4:05:00 PM ET
    $SENS
    Industrial Machinery/Components
    Industrials